These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37883579)

  • 21. STING Activator c-di-GMP-Loaded Mesoporous Silica Nanoparticles Enhance Immunotherapy Against Breast Cancer.
    Chen YP; Xu L; Tang TW; Chen CH; Zheng QH; Liu TP; Mou CY; Wu CH; Wu SH
    ACS Appl Mater Interfaces; 2020 Dec; 12(51):56741-56752. PubMed ID: 33305564
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fibronectin-Coated Metal-Phenolic Networks for Cooperative Tumor Chemo-/Chemodynamic/Immune Therapy via Enhanced Ferroptosis-Mediated Immunogenic Cell Death.
    Xu Y; Guo Y; Zhang C; Zhan M; Jia L; Song S; Jiang C; Shen M; Shi X
    ACS Nano; 2022 Jan; 16(1):984-996. PubMed ID: 35023715
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Injectable thermosensitive black phosphorus nanosheet- and doxorubicin-loaded hydrogel for synergistic bone tumor photothermal-chemotherapy and osteogenesis enhancement.
    Li S; Qing Y; Lou Y; Li R; Wang H; Wang X; Ying B; Tang X; Qin Y
    Int J Biol Macromol; 2023 Jun; 239():124209. PubMed ID: 36972826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Photothermal MnO
    Chen Z; Zhang Q; Huang Q; Liu Z; Zeng L; Zhang L; Chen X; Song H; Zhang J
    Int J Pharm; 2022 Apr; 617():121578. PubMed ID: 35176333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An injectable and tumor-specific responsive hydrogel with tissue-adhesive and nanomedicine-releasing abilities for precise locoregional chemotherapy.
    Wu D; Shi X; Zhao F; Chilengue STF; Deng L; Dong A; Kong D; Wang W; Zhang J
    Acta Biomater; 2019 Sep; 96():123-136. PubMed ID: 31247382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA nanodevice as a multi-module co-delivery platform for combination cancer immunotherapy.
    Nie C; Ye J; Jiang JH; Chu X
    J Colloid Interface Sci; 2024 Aug; 667():1-11. PubMed ID: 38615618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dual pH-responsive multifunctional nanoparticles for targeted treatment of breast cancer by combining immunotherapy and chemotherapy.
    Liu Y; Qiao L; Zhang S; Wan G; Chen B; Zhou P; Zhang N; Wang Y
    Acta Biomater; 2018 Jan; 66():310-324. PubMed ID: 29129789
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nanogel-Incorporated Injectable Hydrogel for Synergistic Therapy Based on Sequential Local Delivery of Combretastatin-A4 Phosphate (CA4P) and Doxorubicin (DOX).
    Yang WJ; Zhou P; Liang L; Cao Y; Qiao J; Li X; Teng Z; Wang L
    ACS Appl Mater Interfaces; 2018 Jun; 10(22):18560-18573. PubMed ID: 29767951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biodegradable electrospun nanofibrous platform integrating antiplatelet therapy-chemotherapy for preventing postoperative tumor recurrence and metastasis.
    Li J; Li J; Yao Y; Yong T; Bie N; Wei Z; Li X; Li S; Qin J; Jia H; Du Q; Yang X; Gan L
    Theranostics; 2022; 12(7):3503-3517. PubMed ID: 35547751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell Membrane Hybrid Lipid Nanovesicles Enhance Innate Immunity for Synergistic Immunotherapy by Promoting Immunogenic Cell Death and cGAS Activation.
    Qian R; Guo Y; Wang R; Wang S; Gao X; Zhu Z; Wang K; Zhu K; Jia B; Chen Y; Wang Z; Ren J; Duan X; Han X
    Biomater Res; 2024; 28():0038. PubMed ID: 38868091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor Microenvironment-Activated Hydrogel Platform with Programmed Release Property Evokes a Cascade-Amplified Immune Response against Tumor Growth, Metastasis and Recurrence.
    Gong S; Liang X; Zhang M; Li L; He T; Yuan Y; Li X; Liu F; Yang X; Shen M; Wu Q; Gong C
    Small; 2022 Dec; 18(50):e2107061. PubMed ID: 36323618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Self-intensified synergy of a versatile biomimetic nanozyme and doxorubicin on electrospun fibers to inhibit postsurgical tumor recurrence and metastasis.
    Hu Y; Xu Y; Mintz RL; Luo X; Fang Y; Lao YH; Chan HF; Li K; Lv S; Chen G; Tao Y; Luo Y; Li M
    Biomaterials; 2023 Feb; 293():121942. PubMed ID: 36512863
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dynamic-Covalent Hydrogel with NIR-Triggered Drug Delivery for Localized Chemo-Photothermal Combination Therapy.
    Sun P; Huang T; Wang X; Wang G; Liu Z; Chen G; Fan Q
    Biomacromolecules; 2020 Feb; 21(2):556-565. PubMed ID: 31804804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polydopamine-doped supramolecular chiral hydrogels for postoperative tumor recurrence inhibition and simultaneously enhanced wound repair.
    Wang X; Wu B; Zhang Y; Dou X; Zhao C; Feng C
    Acta Biomater; 2022 Nov; 153():204-215. PubMed ID: 36108967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In Situ Formed ROS-Responsive Hydrogel with STING Agonist and Gemcitabine to Intensify Immunotherapy against Pancreatic Ductal Adenocarcinoma.
    Wang M; Hu Q; Huang J; Zhang F; Yao Z; Shao S; Zhao X; Liang T
    Adv Healthc Mater; 2023 Aug; 12(20):e2203264. PubMed ID: 36971070
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Injectable in situ forming hydrogels incorporating dual-nanoparticles for chemo-photothermal therapy of breast cancer cells.
    Sabino IJ; Lima-Sousa R; Alves CG; Melo BL; Moreira AF; Correia IJ; de Melo-Diogo D
    Int J Pharm; 2021 May; 600():120510. PubMed ID: 33766636
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Self-delivery of metal-coordinated NIR-II nanoadjuvants for multimodal imaging-guided photothermal-chemodynamic amplified immunotherapy.
    Dai Y; Li X; Xue Y; Chen K; Jiao G; Zhu L; Li M; Fan Q; Dai Y; Zhao Q; Shen Q
    Acta Biomater; 2023 Aug; 166():496-511. PubMed ID: 37230439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunostimulant In Situ Fibrin Gel for Post-operative Glioblastoma Treatment by Macrophage Reprogramming and Photo-Chemo-Immunotherapy.
    Zhang R; Ye Y; Wu J; Gao J; Huang W; Qin H; Tian H; Han M; Zhao B; Sun Z; Chen X; Dong X; Liu K; Liu C; Tu Y; Zhao S
    ACS Appl Mater Interfaces; 2023 Apr; 15(14):17627-17640. PubMed ID: 37000897
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Injectable hydrogel loaded with lysed OK-432 and doxorubicin for residual liver cancer after incomplete radiofrequency ablation.
    Cao Y; Sun T; Sun B; Zhang G; Liu J; Liang B; Zheng C; Kan X
    J Nanobiotechnology; 2023 Nov; 21(1):404. PubMed ID: 37919724
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Doxorubicin-loaded hydrogen peroxide self-providing copper nanodots for combination of chemotherapy and acid-induced chemodynamic therapy against breast cancer.
    Li JX; Zhang LM; Liu CC; Wu QN; Li SP; Lei XP; Huang YG; Feng GN; Yu XY; Sun XQ; Guo ZM; Fu JJ
    J Colloid Interface Sci; 2021 Jul; 593():323-334. PubMed ID: 33744541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.